149 related articles for article (PubMed ID: 23059425)
1. Plasmacytoid dendritic cells: biomarkers or potential therapeutic targets in atherosclerosis?
Grassia G; MacRitchie N; Platt AM; Brewer JM; Garside P; Maffia P
Pharmacol Ther; 2013 Feb; 137(2):172-82. PubMed ID: 23059425
[TBL] [Abstract][Full Text] [Related]
2. Dendritic cells in atherosclerosis: functions in immune regulation and beyond.
Manthey HD; Zernecke A
Thromb Haemost; 2011 Nov; 106(5):772-8. PubMed ID: 21901235
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cells in atherosclerosis: evidence in mice and humans.
Zernecke A
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):763-70. PubMed ID: 25675999
[TBL] [Abstract][Full Text] [Related]
4. Analysis of HLDA9 mAbs on plasmacytoid dendritic cells.
Cabezón R; Sintes J; Llinàs L; Benitez-Ribas D
Immunol Lett; 2011 Jan; 134(2):167-73. PubMed ID: 20933012
[TBL] [Abstract][Full Text] [Related]
5. Vinpocetine Inhibited the CpG Oligodeoxynucleotide-induced Immune Response in Plasmacytoid Dendritic Cells.
Feng X; Wang Y; Hao Y; Ma Q; Dai J; Liang Z; Liu Y; Li X; Song Y; Si C
Immunol Invest; 2017 Apr; 46(3):263-273. PubMed ID: 27967259
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical characterisation of dendritic cells in human atherosclerotic lesions: possible pitfalls.
Van Vré EA; Bosmans JM; Van Brussel I; Maris M; De Meyer GR; Van Schil PE; Vrints CJ; Bult H
Pathology; 2011 Apr; 43(3):239-47. PubMed ID: 21436634
[TBL] [Abstract][Full Text] [Related]
7. Plasmacytoid dendritic cells act as the most competent cell type in linking antiviral innate and adaptive immune responses.
Zhang Z; Wang FS
Cell Mol Immunol; 2005 Dec; 2(6):411-7. PubMed ID: 16426490
[TBL] [Abstract][Full Text] [Related]
8. Trafficking properties of plasmacytoid dendritic cells in health and disease.
Sozzani S; Vermi W; Del Prete A; Facchetti F
Trends Immunol; 2010 Jul; 31(7):270-7. PubMed ID: 20579936
[TBL] [Abstract][Full Text] [Related]
9. Circulating plasmacytoid dendritic cells in patients with primary and Helicobacter pylori-associated immune thrombocytopenia.
Saito A; Yokohama A; Osaki Y; Ogawa Y; Nakahashi H; Toyama K; Mitsui T; Hashimoto Y; Koiso H; Uchiumi H; Saitoh T; Handa H; Sawamura M; Karasawa M; Murakami H; Tsukamoto N; Nojima Y
Eur J Haematol; 2012 Apr; 88(4):340-9. PubMed ID: 22221143
[TBL] [Abstract][Full Text] [Related]
10. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection.
Martinet J; Leroy V; Dufeu-Duchesne T; Larrat S; Richard MJ; Zoulim F; Plumas J; Aspord C
Hepatology; 2012 Nov; 56(5):1706-18. PubMed ID: 22707082
[TBL] [Abstract][Full Text] [Related]
11. Plasmacytoid dendritic cells and cancer.
Vermi W; Soncini M; Melocchi L; Sozzani S; Facchetti F
J Leukoc Biol; 2011 Oct; 90(4):681-90. PubMed ID: 21730085
[TBL] [Abstract][Full Text] [Related]
12. Rheumatoid arthritis synovium contains plasmacytoid dendritic cells.
Cavanagh LL; Boyce A; Smith L; Padmanabha J; Filgueira L; Pietschmann P; Thomas R
Arthritis Res Ther; 2005; 7(2):R230-40. PubMed ID: 15743469
[TBL] [Abstract][Full Text] [Related]
13. Plasmacytoid dendritic cells are present in cutaneous dermatomyositis lesions in a pattern distinct from lupus erythematosus.
McNiff JM; Kaplan DH
J Cutan Pathol; 2008 May; 35(5):452-6. PubMed ID: 18005168
[TBL] [Abstract][Full Text] [Related]
14. Auto-antigenic protein-DNA complexes stimulate plasmacytoid dendritic cells to promote atherosclerosis.
Döring Y; Manthey HD; Drechsler M; Lievens D; Megens RT; Soehnlein O; Busch M; Manca M; Koenen RR; Pelisek J; Daemen MJ; Lutgens E; Zenke M; Binder CJ; Weber C; Zernecke A
Circulation; 2012 Apr; 125(13):1673-83. PubMed ID: 22388324
[TBL] [Abstract][Full Text] [Related]
15. Atherosclerosis and autoimmunity: a growing relationship.
Sanjadi M; Rezvanie Sichanie Z; Totonchi H; Karami J; Rezaei R; Aslani S
Int J Rheum Dis; 2018 May; 21(5):908-921. PubMed ID: 29671956
[TBL] [Abstract][Full Text] [Related]
16. Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-alpha.
Niessner A; Sato K; Chaikof EL; Colmegna I; Goronzy JJ; Weyand CM
Circulation; 2006 Dec; 114(23):2482-9. PubMed ID: 17116765
[TBL] [Abstract][Full Text] [Related]
17. Plasmacytoid dendritic cells employ multiple cell adhesion molecules sequentially to interact with high endothelial venule cells--molecular basis of their trafficking to lymph nodes.
Matsutani T; Tanaka T; Tohya K; Otani K; Jang MH; Umemoto E; Taniguchi K; Hayasaka H; Ueda K; Miyasaka M
Int Immunol; 2007 Sep; 19(9):1031-7. PubMed ID: 17804686
[TBL] [Abstract][Full Text] [Related]
18. The expression of vascular dendritic cells in human atherosclerotic carotid plaques.
Kawahara I; Kitagawa N; Tsutsumi K; Nagata I; Hayashi T; Koji T
Hum Pathol; 2007 Sep; 38(9):1378-85. PubMed ID: 17555794
[TBL] [Abstract][Full Text] [Related]
19. Plasmacytoid dendritic cells in atherosclerosis.
Döring Y; Zernecke A
Front Physiol; 2012; 3():230. PubMed ID: 22754539
[TBL] [Abstract][Full Text] [Related]
20. Systemic lupus erythematosus patients have increased number of circulating plasmacytoid dendritic cells, but decreased myeloid dendritic cells with deficient CD83 expression.
Jin O; Kavikondala S; Sun L; Fu R; Mok MY; Chan A; Yeung J; Lau CS
Lupus; 2008 Jul; 17(7):654-62. PubMed ID: 18625638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
